Jubilant Pharmova Ltd - 530019 - Announcement Under Regulation 30 - USFDA Report For Jubilant Cadista Pharmaceuticals Inc., USA

Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

1204.9000 10.90 (0.91%)

NSE Jul 15, 2025 13:11 PM

71.69% Gain from 52W Low

Volume: 123.8K

Jubilant Pharmova Ltd.

12 Mar 2025

1204.90

0.91%

Company Update

Jubilant Pharmova Ltd - 530019 - Announcement Under Regulation 30 - USFDA Report For Jubilant Cadista …

BSE India

Announcement under Regulation 30 - USFDA Report for Jubilant Cadista Pharmaceuticals INC., USA

More from Jubilant Pharmova Ltd.

Recommended

Market trades higher, Power Mech bags a Rs 498.3 crore order from SJVN

Trendlyne Marketwatch | 15 Jul 2025, 01:03PM

IPO spree continues with Anthem and two SME issues opening this week

| 14 Jul 2025, 04:42PM

Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences